Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2014

Jan 10, 2014

29745_dirs_2014-01-10_d615768d-1e0a-44ca-acc9-615e8abd1de1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-01-01

Reporting Person: Zulueta Alfonso G (SVP& Pres., Emerging Markets)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 22830 Direct
Common Stock 3957 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee stock option 2/04 (right to buy) $73.11 2014-02-14 Common Stock (40000.0) Direct
Employee stock option 2/05 (right to buy) $55.65 2015-02-10 Common Stock (21302.0) Direct
Employee stock option 2/06 (right to buy) $56.18 2016-02-09 Common Stock (12048.0) Direct
Restricted Stock Unit $ 2014-10-01 Common Stock (9333.0) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.